544671-91-2Relevant academic research and scientific papers
Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H- pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones as NK1 antagonists
Seto, Shigeki,Tanioka, Asao,Ikeda, Makoto,Izawa, Shigeru
, p. 1479 - 1484 (2007/10/03)
Novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones were designed and prepared as part of a search for NK1 antagonists. Structure-activity relationship studies indicated that the conformational restri
Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9- tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists
Seto, Shigeki,Tanioka, Asao,Ikeda, Makoto,Izawa, Shigeru
, p. 5717 - 5732 (2007/10/03)
A series of novel bicyclic pyrimidine derivatives was prepared as part of a search for NK1 antagonist aimed at the treatment of urinary incontinence. Among them, 3g, a pyrimido[4,5-b][1,5]oxazocine derivative, bearing a 4-acetylpiperazinyl grou
FUSED BICYCLIC PYRIDINE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS
-
Page 35, (2010/02/08)
A novel fused bicyclic pyridine derivative or a salt thereof that acts as a tachykinin receptor antagonist, in particular as an NK1 receptor antagonist, is represented by the following general formula (1): ???wherein the rings A and B are each a benzene'r
FUSED BICYCLIC PYRIDINE DERIVATIVE AS TACHYKININ RECEPTOR ANTAGONIST
-
Page 21, (2010/02/09)
A fused bicyclic pyridine derivative represented by the following general formula (1), or a salt thereof: ???wherein the rings A and B are each a benzene ring, which may have 1 to 3 substituents (any adjacent two of which may be bound to one another to fo
